Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2013

01-01-2013 | Original Paper

The Development of an Inventory to Assess the Structural Barriers to Clinic Attendance and Pill-taking Amongst Users of Antiretroviral Therapy

Authors: Bronwyne Coetzee, Ashraf Kagee

Published in: AIDS and Behavior | Issue 1/2013

Login to get access

Abstract

In addition to personal and psychological factors, structural factors may reduce the likelihood of optimal adherence to antiretroviral therapy (ART) among persons living with HIV. In this mixed-method study we report on the development of a scale to assess the salience of various structural barriers to ART adherence. After following conventional guidelines for scale development, two scales measuring structural barriers to adherence to clinic attendance and pill-taking were administered to 291 patients receiving ART at a public hospital in South Africa. Both exploratory and higher order factor analysis indicated that a single underlying general factor was appropriate for both scales. The final scales consisted of 12 items for the structural barriers to clinic attendance scale and 13 items for the structural barriers to medication-taking scale. Both scales displayed excellent internal consistency with Cronbach alpha coefficients above 0.80. Research to determine the construct validity of the scales may be a next step in this line of research.
Literature
1.
Joint United Nations Programme on HIV/AIDS. Global Report: UNAIDS report on the global AIDS epidemic. 2010.
2.
Nischal KC, Khopkar U, Saple DG. Improving adherence to antiretroviral therapy. Indian J Dermatol Venereol Leprol. 2005;71(5):316–20.PubMedCrossRef
3.
Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90.PubMedCrossRef
4.
Sledjeski EM, Delahanty DL, Bogart LM. Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIV. AIDS Patient Care STDS. 2005;19(11):728–36.PubMedCrossRef
5.
Kalichman SC, Rompa D, DiFonzo K, Simpson D, Austin J, Luke W, et al. HIV treatment adherence in women living with HIV/AIDS: research based on the information–motivation–behavioral skills model of health behavior. J Assoc Nurses AIDS Care. 2001;12(4):58–67.PubMedCrossRef
6.
Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999;14(5):267–73.PubMedCrossRef
7.
Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34(3):281–8.PubMedCrossRef
8.
Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13(13):1763–9.PubMedCrossRef
9.
Berg CJ, Michelson SE, Safren SA. Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors. Infect Dis Clin North Am 2007; 21(1):181–200, x.
10.
Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006;18(8):904–10.PubMedCrossRef
11.
Shriver MD, Everett C, Morin SF. Structural interventions to encourage primary HIV prevention among people living with HIV. AIDS. 2000;14(Suppl 1):S57–62.PubMedCrossRef
12.
Kagee A, Remien RH, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health. 2011;6(1):83–97.PubMedCrossRef
13.
Coetzee B, Kagee A, Vermeulen N. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers. AIDS Care. 2011;23(2):146–51.PubMedCrossRef
14.
Kagee A, Delport T. Barriers to adherence to antiretroviral treatment: the perspectives of patient advocates. J Health Psychol. 2010;15(7):1001–11.PubMedCrossRef
15.
Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.PubMedCrossRef
16.
Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, et al. “That is why I stopped the ART”: patients’ & providers’ perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008;18(8):63.CrossRef
17.
Roura M, Busza J, Wringe A, Mbata D, Urassa M, Zaba B. Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: a follow-up study to understand attrition from the antiretroviral program. AIDS Patient Care STDS. 2009;23(3):203–10.PubMedCrossRef
18.
Swartz L, Dick J. Managing chronic diseases in less developed countries. BMJ. 2002;325(7370):914–5.PubMedCrossRef
19.
Cole FL, Abel C. Climate of care and nurses’ attitudes towards AIDS in the emergency department. Emerg Nurse. 2000;8(4):18–24.PubMed
20.
Gueritault-Chalvin V, Kalichman SC, Demi A, Peterson JL. Work-related stress and occupational burnout in AIDS caregivers: test of a coping model with nurses providing AIDS care. AIDS Care. 2000;12(2):149–61.PubMedCrossRef
21.
Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M, et al. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care. 2009;21(1):78–86.PubMedCrossRef
22.
Smit R. HIV/AIDS and the workplace: perceptions of nurses in a public hospital in South Africa. J Adv Nurs. 2005;51(1):22–9.PubMedCrossRef
23.
Maskew M, MacPhail P, Menezes C, Rubel D. Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007;97(9):853–7.PubMed
24.
Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health. 2008;13(7):904–13.PubMedCrossRef
25.
Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14(4):778–84.PubMedCrossRef
26.
Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S127–33.PubMedCrossRef
27.
Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS ONE. 2010;5(4):e10340.PubMedCrossRef
28.
Brown L, Macintyre K, Trujillo L. Interventions to reduce HIV/AIDS stigma: what have we learned? AIDS Educ Prev. 2003;15(1):49–69.PubMedCrossRef
29.
Derlega VJ, Winstead BA, Greene K, Serovich J, Elwood WN. Perceived HIV-related stigma and HIV disclosure to relationship partners after finding out about the seropositive diagnosis. J Health Psychol. 2002;7(4):415–32.PubMedCrossRef
30.
Nothling J. Strukturele hindernisse tot ART volhoubaarheidheid onder MIV positiewe pasiënte. Unpublished Masters Thesis, Stellenbosch University; 2009.
31.
De Vellis RF (1991) Scale development: theory and applications. Applied Social Research Methods Series. Newbury Park: SAGE.
32.
Bolton P, Wietse A, Tol JB. Introduction to special issue: combining qualitative and quantitative research methods to support psycho social and mental health programmes. Intervention. 2009;7(3):181–6.CrossRef
33.
Stevens J. Applied multivariate statistics for the social sciences. 2nd ed. Hillsdale: Erlbaum; 1992.
34.
Schmid J, Leiman JM. The development of hierarchical factor solutions. Psychometrika. 1957;22:53–61.CrossRef
35.
De Bruin D. The dimensionality of the general work scale. A hierarchical exploratory factor analysis. SA J Ind Psychol. 2006;32(4):68–75.
36.
Field AP. Discovering statistics using SPSS: (and sex, drugs and rock’n’roll). 2nd ed. London: SAGE; 2005.
37.
Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39:31–6.CrossRef
38.
Miles KK, Clutterbuck DJ, Seitio OO, Sebego MM, Riley AA. Antiretroviral treatment roll-out in a resource-constrained setting: capitalizing on nursing resources in Botswana. Bull World Health Organ. 2007;85(7):555–60.PubMedCrossRef
39.
Jaffar S, Govender T, Garrib A, Welz T, Grosskurth H, Smith PG, et al. Antiretroviral treatment in resource-poor settings: public health research priorities. Trop Med Int Health. 2005;10(4):295–9.PubMedCrossRef
40.
Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology. 2008;1(5):13.CrossRef
41.
Nguyen VK, Ako CY, Niamba P, Sylla A, Tiendrebeogo I. Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment. AIDS. 2007;21(Suppl 5):S31–5.PubMedCrossRef
42.
Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. 2006;20(5):359–68.PubMedCrossRef
43.
Duff P, Kipp W, Wild TC, et al. Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. J Int AIDS Soc. 2010;13:37.PubMedCrossRef
44.
Johnson LF. Access to antiretroviral treatment in South Africa, 2004–2011. S Afr J HIV Med. 2012;13(1):22–7.
45.
Dorrington RE, Johnson LF, Bradshaw D, Daniel T. The demographic impact of HIV/AIDS in South Africa. National and Provincial indicators for 2006. Cape Town: Centre for Actuarial Research, South African Medical Research Council and Actuarial Society of South Africa; 2006.
46.
Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Le GM. Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV + men and women in four US cities. AIDS Behav. 2003;7(1):61–72.PubMedCrossRef
47.
Tomlinson M, Rohleder P, Swartz L, Drimie S, Kagee A. Broadening psychology’s contribution to addressing issues of HIV/AIDS, poverty and nutrition: structural issues as constraints and opportunities. J Health Psychol. 2010;15(7):972–81.PubMedCrossRef
48.
Ivers LC, Chang Y, Gregory Jerome J, Freedberg KA. Food assistance is associated with improved body mass index, food security and attendance at clinic in an HIV program in central Haiti: a prospective observational cohort study. AIDS Res Ther. 2010;26(7):33.CrossRef
Metadata
Title
The Development of an Inventory to Assess the Structural Barriers to Clinic Attendance and Pill-taking Amongst Users of Antiretroviral Therapy
Authors
Bronwyne Coetzee
Ashraf Kagee
Publication date
01-01-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0374-z

Other articles of this Issue 1/2013

AIDS and Behavior 1/2013 Go to the issue

Original Paper

Assessing HIV/AIDS Stigma in South India: Validation and Abridgement of the Berger HIV Stigma Scale

Original Paper

Age Cohort Differences in the Effects of Gay-Related Stigma, Anxiety and Identification with the Gay Community on Sexual Risk and Substance Use

Original Paper

The Role of Multiple Identities in Adherence to Medical Appointments Among Gay/Bisexual Male Adolescents Living with HIV

Original Paper

Is the US AIDS Drug Assistance Program Cost-effective?

Brief Report

No Association Found Between Traditional Healer Use and Delayed Antiretroviral Initiation in Rural Uganda

Original Paper

Patterns of HIV Disclosure and Condom Use Among HIV-Infected Young Racial/Ethnic Minority Men Who Have Sex with Men
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits